Multiple Myeloma Stem Cell Transplant Recovery

There can be a long period of dormancy that could.

Multiple myeloma stem cell transplant recovery.

Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body. The 2 most common problems after this type of transplant are. Autologous stem cell transplantation is more common for multiple myeloma but either type of transplant can be used. Learn about the procedure costs risks and recovery of a bone marrow transplant.

The risk of infection is higher and lasts longer than in transplants using your own stem cells. The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy. And the risk of side effects or complications is higher. The recovery of polyclonal ig was defined as normalization of all values of serum igg iga and igm 1 year after asct.

Diagnosed with multiple myeloma in august 2010 she had a stem cell transplant in march 2011 and as of september 2013 was on post transplant maintenance bio therapy at dana farber brigham and women s cancer center. Charlie rider had a stem cell transplant at dana farber as young boy. We retrospectively analyzed multiple myeloma mm patients who underwent autologous stem cell transplantation asct without maintenance therapy to assess the impact of recovery of normal immunoglobulin ig on clinical outcomes. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival.

See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic. A particular complication of donor transplants called graft versus host disease. Recovery after a donor transplant takes much longer. People who have autologous or allogeneic transplants first receive high dose chemotherapy to kill the cancer cells.

For an autologous stem cell transplant the. Stem cell transplants have become important weapons in the fight against certain blood cancers such as multiple myeloma non hodgkin s lymphoma hodgkin lymphoma and leukemia a stem cell. Multiple myeloma isn t considered curable but symptoms wax and wane. One viable treatment option for multiple myeloma patients is a stem cell transplant.

In some cases a bone marrow or stem cell transplant is an option.